Cardiac Amyloidosis: When the Presentation Misleads

Case reports · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

Follow physiology across organ systems, then confirm the specific disease.

Cardiac Amyloidosis: When the Presentation Misleads: six-panel learning summary. Full text follows below.
Download infographic (PNG) · Download Markdown · Read text version ·

Text version

A presentation outside cardiology

Ascites, kidney dysfunction, or apparent liver disease may be driven partly by cardiac congestion. Revisit the working diagnosis when the history and physiology do not fit the initial label.

Ejection fraction has limits

Preserved ejection fraction does not guarantee adequate forward flow or normal filling pressures. Chamber size, stroke volume, diastolic function, and right-sided findings add essential information.

Use fluid and hemodynamic clues

Interpret ascitic fluid studies and, when indicated, right-heart catheterization in the full clinical context. No isolated pressure relationship or fluid-protein result proves infiltrative disease.

Screen for a monoclonal protein

A proper AL screen includes serum and urine immunofixation and serum free light chains. Renal impairment affects interpretation; a negative single test is not the entire screen.

Use amyloid testing correctly

Bone-tracer scintigraphy can support an ATTR pathway only under the appropriate diagnostic conditions. A monoclonal protein changes the interpretation and may require tissue typing.

Treat the established disease

AL and ATTR amyloidosis have different treatments. Coordinate typing, staging, congestion management, and shared goals of care. Avoid therapeutic decisions based only on a suggestive echocardiogram.

Continue learning

This graphic summarizes a topic. The full educational pages provide the broader discussion and references.